JPM: Alnylam CEO outlines aggressive plan to catapult into biotech’s top 5MedicaloidJanuary 11, 2021 January 11, 2021Alnylam CEO John Maraganore officially has a new-and-lofty goal: Vault the RNAi-focused company into the top five biotechs by market cap—by 2025. What’ll that take?...
